You are here
Luca Pasina, Gianluigi Casadei, Alessandro Nobili
European Journal of Internal Medicine, Volume 33, September 2016, Pages 28 - 35
Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data
Elena Nikiphorou, Hannu Kautiainen, Pekka Hannonen, Juha Asikainen, Arto Kokko, Tuomas Rannio & Tuulikki Sokka pages 1677-1683Expert Opinion on Biological Therapy, Volume 15, Issue 12, 2015
Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.
Woodworth TG, den Broeder AA.Best Practice & Research Clinical Rheumatology, Volume 29, Issues 4–5, August–December 2015, Pages 543–549